Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.39 USD | +8.65% | +13.38% | +171.20% |
21/05 | Lexaria Bioscience Secures New Hypertension, Epilepsy Patents in US; Shares Rise | MT |
17/05 | Lexaria Bioscience Corp. Announces Dosing Begins in Comprehensive GLP-1 Animal Study | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+171.20% | 43.68M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.47% | 238B | |
+7.35% | 204B | |
-6.42% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- Transcript : Lexaria Bioscience Corp. Presents at Benzinga Virtual Global Small Cap Conference, May-13-2021 03